Use of sulprostone in the medical evacuation of uterine contents.
DOI:
https://doi.org/10.20344/amp.2566Abstract
The authors describe a one year experience in the Viseu District Hospital Maternity with the use of prostaglandin E2 analog Sulprostone to expel the conceptus. The drug was used in continuous intra-venous administration using a dilution of 1000 mcg of sulprostone in 1000 cc of saline solution. Initially the infusion rate was 0,90 mcg/min (XVIII drops/min) which, was altered to 1,50 mcg/min (XXX drops/min) after a meeting in Espinho in the spring of 1994. The results are presented as success (complete expulsion of uterine contents), partial success and failure. Success (complete and partial) was obtained in 33 cases (62%) and failure in 20 cases (38%). The longer the gestational age the more effective was the drug. Tolerance was very good. We concluded that Sulprostone is an excellent method for medical emptying of the uterus in second and third trimesters.Downloads
Downloads
How to Cite
Issue
Section
License
All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.
It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.
Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.
After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.
